Clinical Trial Update: Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing tolerability of Antistax in patients with chronic venous insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency

Drugs mentioned

• Antistax (red vine leaf extract)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Insufficiency | Phase 4 | Status: COMPLETED